Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial
Open Access
- 1 August 2020
- journal article
- research article
- Published by American Thoracic Society in Annals of the American Thoracic Society
- Vol. 17 (8), 1008-1015
- https://doi.org/10.1513/annalsats.202004-309sd
Abstract
COVID-19 is a potentially fatal illness with no proven therapy beyond excellent supportive care. Treatments are urgently sought. Adaptations to traditional trial logistics and design to allow rapid implementation, evaluation of trials within a global trials context, flexible interim monitoring, and access outside traditional research hospitals (even in settings where formal placebos are unavailable) may be helpful. Thoughtful adaptations to traditional trial designs—especially within the global context of related studies—may also foster collaborative relationships among government, community, and the research enterprise. We describe here the protocol for a pragmatic, active comparator trial in as many as 300 patients comparing two current “off-label” treatments for COVID-19—hydroxychloroquine and azithromycin—in academic and non-academic hospitals in Utah. We developed the trial in response to local pressures for widespread, indiscriminate off-label use of these medications. We employ a hybrid Bayesian-frequentist design for interim monitoring to allow rapid, contextual assessment of the available evidence. We also developed an inference grid for the interpretation of the range of possible results from this trial within the context of parallel trials and prepared for network meta-analysis of the resulting data. This trial was prospectively registered (NCT04329832) before enrollment of the first patient.Keywords
This publication has 46 references indexed in Scilit:
- Macrolide Antibiotics and Survival in Patients With Acute Lung InjurySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Azithromycin and the Risk of Cardiovascular DeathThe New England Journal of Medicine, 2012
- Hospital Admission Decision for Patients With Community-Acquired Pneumonia: Variability Among Physicians in an Emergency DepartmentAnnals of Emergency Medicine, 2012
- Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological studyBMJ, 2011
- Azithromycin induces anti-viral responses in bronchial epithelial cellsEuropean Respiratory Journal, 2010
- Practical Bayesian Design and Analysis for Drug and Device Clinical TrialsJournal of Biopharmaceutical Statistics, 2007
- Usual Care as the Control Group in Clinical Trials of Nonpharmacologic InterventionsProceedings of the American Thoracic Society, 2007
- Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress SyndromeThe New England Journal of Medicine, 2004
- Network meta‐analysis for indirect treatment comparisonsStatistics in Medicine, 2002
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeThe New England Journal of Medicine, 2000